4.7 Review

Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?

Luis C. Borbon et al.

Summary: This study evaluated outcomes of surgically treated Grade 3 gastroenteropancreatic neuroendocrine neoplasm (G3 GEP-NEN) patients, finding a significantly lower overall survival rate in resected G3 NEN patients compared to those with Grade 1/2 tumors. Surgical resection of G3 GEP-NENs remains controversial, but for carefully selected patients, especially those with well-differentiated tumors, surgery may be a consideration.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Surgery

Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?

Lucas W. Thornblade et al.

Summary: By studying patients with non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms, it was found that surgical treatment confers a significant survival advantage over systemic therapy, with longer median survival time and higher 5-year overall survival rates.

SURGERY (2021)

Article Endocrinology & Metabolism

Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Hans-Christian Pommergaard et al.

Summary: The study found that surgery for high-grade GEP NEN and MiNEN patients can lead to good long-term outcomes, especially for those who can achieve R0 resection. However, surgery may not extend survival for patients in stage IV.

JOURNAL OF NEUROENDOCRINOLOGY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Editorial Material Cell Biology

The 2019 WHO classification of tumours of the digestive system

Iris D. Nagtegaal et al.

HISTOPATHOLOGY (2020)

Article Gastroenterology & Hepatology

Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals

Zhi-Jie Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Endocrinology & Metabolism

The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond

Halfdan Sorbye et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)

Article Pathology

Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases

Olca Basturk et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)

Article Health Care Sciences & Services

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

Patricia Guyot et al.

BMC MEDICAL RESEARCH METHODOLOGY (2012)

Article Medicine, General & Internal

Meta-analysis of individual participant data: rationale, conduct, and reporting

Richard D. Riley et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Medicine, Research & Experimental

Practical methods for incorporating summary time-to-event data into meta-analysis

Jayne F. Tierney et al.

TRIALS (2007)